Paolo A. Ascierto


Paolo A. Ascierto
Paolo A. Ascierto, MD, is Vice-Director of the Unit of Medical Oncology and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples (Italy). He earned his medical degree from the University of Naples, where he earned board certification in oncology. Before the present position at the Unit of Medical Oncology and Innovative Therapy of the National Tumor Institute, he previously served there as a postdoctoral fellow and then vice director of the Department of Clinical Immunology. Major research interests have included genetics and proteomics research of melanoma, apoptosis and cell death in human cancer, assessment of new molecular markers for tumor progression in patients with malignant melanoma, as well as targeted therapies for melanoma, biochemical and immunological monitoring, and vaccination treatments. He has served as principal investigator in numerous clinical trials and has been well-published in peer-reviewed journals on topics related to his interests. Dr. Ascierto serves on the editorial boards of the Journal of Translational Medicine, the Combination Products in Therapy, the Journal of Skin Cancer, the Journal of Molecular Biomarkers & Diagnosis, and the Dataset Papers in Immunology. He is the Editor in Chief of the Combination Strategies section of the Journal of Translational Medicine. He has been an invited speaker at more than 200 national and international meetings, and maintains active memberships in several medical societies in Italy and abroad.  



 


For information please contact info@melanomabridge.org